Osama Abdelaziz

Prof. Dr. Osama Abdelaziz


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1999 in Surgical Neurology
Verified
Journal Article
Closed access
OAOsama Abdelaziz
Osama Abdelaziz
COChristopher S Ogilvy
Christopher S Ogilvy
MLMichael Lev
Michael Lev

20 July 2020 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
OAOsama Abdelaziz
Osama Abdelaziz
ZWZuraiha Waffa
Zuraiha Waffa

1 January 1999 in Stereotactic and Functional Neurosurgery
Verified
Journal Article
Closed access
PDF file
FMFardad Mobin
Fardad Mobin
ASAntonio A.F. De Salles
Antonio A.F. De Salles
OAOsama Abdelaziz
Osama Abdelaziz
CCCynthia Cabatan-Awang
Cynthia Cabatan-Awang
TSTimothy Solberg
Timothy Solberg
MSMichael Selch
Michael Selch
The purpose of this study was to analyze the significance of perinidal T2 hyperintensity appearance after radiosurgery of arteriovenous malformations (AVMs), as a predictor of treatment response. Our initial experience with linear accelerator (LINAC) radiosurgery at University of California, Los Angeles, between 1990 and 1997 involved treatment of 129 patients affected by cerebral AVMs. Based upon availability of neuroimaging follow-up, 48 patients with 50 AVMs were selected for review. Forty (80%) of the AVMs underwent complete obliteration or significant reduction on follow-up MRI, on average 20 months after radiosurgery. Thirteen (72%) of 18 obliterated AVMs were associated with perinidal T2 hyperintensity signal, on average 18 months (6–49) after radiosurgery. Ten (20%) of 50 AVMs (average volume 23.1 cm3, ranging 7.5–46.5) were unchanged. Furthermore, only 3 AVMs in this group showed reversible T2 signal changes. In patients with complete nidal obliteration, appearance of T2 hyperintensity signal achieves 72% sensitivity in predicting successful treatment response.

9 October 2010 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
OAOsama Abdelaziz
Osama Abdelaziz
AKAlaa Kandil
Alaa Kandil
SEShaaban El-Assaal
Shaaban El-Assaal
OAOsama Abdelaziz
Osama Abdelaziz
YRYosry Rostom
Yosry Rostom
YRYaser Rashed
Yaser Rashed

1 September 2010 in Neurosurgery Quarterly
Verified
Journal Article
Closed access
OAOsama Abdelaziz
Osama Abdelaziz
AMAhmed Marie
Ahmed Marie
MAMohamed Abbas
Mohamed Abbas
MIMohamed Ibrahim
Mohamed Ibrahim
HGHala Gabr
Hala Gabr
Bone marrow is a readily accessible source for autologous adult bone marrow stem cells which can be applied therapeutically without possessing the risk of immune rejection and without raising ethical concerns. The purpose of this study is to determine the feasibility, safety, and effectiveness of direct transplantation of autologous adult bone marrow stem cells in patients with chronic cord injuries. Thirty consecutive patients (5 females and 25 males, aged 6 to 64 y) having chronic traumatic dorsal spinal cord injury with durations of at least 6 months were included in the study. Twenty patients were treated with autologous adult bone marrow stem cells transplantation through open surgical intraparenchymal and intralesional injection into the site of cord injury. The treatment was continued with monthly intrathecal injection of stem cells through lumbar or cisternal punctures. Ten other patients were not treated with stem cells and served as control cases. Clinical improvement was observed in 6 (30%) of 20 patients treated with stem cells transplantation. Short duration of injury and small cord lesions correlated with good outcome. Follow-up electrophysiologic studies did not show statistically significant changes. Follow-up magnetic resonance imaging did not show significant changes. Minor and temporary treatment-related morbidity were recorded. The application of autologous adult bone marrow mesenchymal stem cells directly into the spinal cord is relatively safe and has clinical benefits in patients with chronic spinal cord injury. However, multicenter studies should be conducted to further elucidate the safety and efficacy of stem cells therapy in patients with spinal cord injury.

20 March 2019 in Journal of Neurological Surgery Part A: Central European Neurosurgery
Verified
Journal Article
Closed access
PDF file
OAOsama Abdelaziz
Osama Abdelaziz
ASAhmed Shereen
Ahmed Shereen
TITakuro Inoue
Takuro Inoue
HHHisao Hirai
Hisao Hirai
ASAyako Shima
Ayako Shima
Background A wide variety of radiologic changes occur within and adjacent to the nidus of arteriovenous malformations (AVMs) after stereotactic radiosurgery (SRS). Our objective was to study the magnetic resonance imaging(MRI)-defined changes following photon radiosurgery of AVMs and specifically to correlate the appearance of a perinidal T2 hyperintensity signal with the eventual angiographic obliteration of an AVM nidus in response to SRS treatment. Material and Methods This retrospective study was conducted on 62 patients with brain AVMs who received photon SRS treatments between 2004 and 2017, using either a technique based on a linear accelerator at the Alexandria LINAC Radiosurgery Center in Egypt (21 patients/AVMs) or a technique based on a gamma unit at the Koto Memorial Gamma Knife Center in Japan (41 patients/AVMs). All patients included in the study had serial clinical and radiologic follow-ups for ≥ 2 years after SRS treatments. Results In the combined study series of 62 patients/AVMs treated with photon SRS, the follow-up MRIs revealed that 50 AVMs (80.6%) showed nonvisualized nidus and 12 AVMs (19.4%) showed decreased nidus size. Radiation-induced changes, defined as appearance of perinidal T2 hyperintensities in post-SRS MRIs, occurred in 34 patients (54.8%). Of the 35 patients with available follow-up angiographic studies, 30 AVMs (85.7%) demonstrated complete nidus obliteration at a mean of 36 months (range: 8–66 months) after SRS. Of the 30 AVMs with both MRI evidence of a nonvisualized nidus and angiographic verification of complete nidus obliteration, 20 AVMs (66.7%) were associated with prior MRI evidence of the appearance of a perinidal T2 hyperintensity signal at an average of 12 months (range: 6–45 months) after SRS. Of the five AVMs with both MRI evidence of decreased nidus size and angiographic verification of partial nidus obliteration, four AVMs (80%) showed perinidal T2 hyperintensity signal on post-SRS follow-up MRIs. Lower Spetzler-Martin grade (p = 0.013), smaller AVM volume (p = 0.017), and appearance of post-SRS perinidal T2 hyperintensity signal (p = 0.007) were the statistically significant independent predictors of AVM obliteration. The appearance of perinidal T2 hyperintensity signal in the post-SRS MRIs had a sensitivity of 66.7%, a specificity of 20%, and an overall accuracy of 60% in predicting the eventual obliteration of the AVM nidus. Conclusions The present study may help improve our current understanding of the mechanisms behind the radiation-induced tissue changes following AVM SRS. Because the SRS-induced hemodynamic changes within the AVM nidus initiate the cascade of the subsequent formation of perinidal vasogenic brain edema, the appearance of perinidal high T2 signal in the follow-up MRIs after SRS would be a valuable indicator of the AVM response to SRS. The development of perinidal hyperintensity was the strongest predictive factor of AVM obliteration (p = 0.007), with relatively high sensitivity (66.7%) and accuracy (60%) and fairly low specificity (20%), as a prognostic sign of eventual complete angiographic obliteration of the AVM nidus following SRS.